Conclusion: OS and PFS outcomes were superior to those observed in prior studies evaluating sorafenib alone in patients with a similar disease status, warranting further study of this treatment combination.
://www.dovepress.com/yttrium-90-resin-microspheres-as-an-adjunct-to-sorafenib-in-patients-w-peer-reviewed-article-JHC
Conclusion: OS and PFS outcomes were superior to those observed...
Add to My Watchlist
What is My Watchlist?